This site is for healthcare professionals and doctors only


At Correvio, we have established an integrated pharmaceutical platform incorporating production, distribution, regulatory, medical, health economics, marketing and sales. This comprises a direct pan-European commercial operation and a network of distributors and partners extending reach to over 50 countries worldwide.

Patients First

Our business approach is to partner with healthcare professionals to help find the best therapeutic solution for their patients. We constantly monitor relevant trends and developments to assist healthcare professionals in decision making, improve care delivery and ultimately improve patient outcomes. In this context, we measure our success with Aggrastat® (tirofiban HCl)* according to the number of Major Adverse Cardiac Events (MACE) prevented.

Our Team

We specialize in critical care with a deep understanding of interventional cardiology. Our team offers our customers a thorough knowledge of the science, patient care pathways, networks of care and treatment guidelines that are relevant to the therapeutic area we serve. Our Medical Information Centre (MIC) is available to provide medical information support wherever needed.

* Aggrastat® 50 microgram/ml solution for infusion.
Aggrastat® 250 microgram/ml concentrate for solution for infusion.


  • EU Details

    Correvio International Sàrl
    Rue des Alpes 21
    Case Postale 1674
    1201 Geneva Switzerland

  • US Details

    Correvio LLC
    3 Dickinson Drive, Suite 101
    Chadds Ford, PA 19317

  • Phone

    EU-Phone : +41 (0) 22 907 79 70
    US-Phone : +1 610 833 6050

  • Email

    Information :